We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $550B
1-Year Est. Return 43.33%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+29.03%
1 Year Est. Return
+43.33%
3 Year Est. Return
+132.06%
5 Year Est. Return
+165.07%
10 Year Est. Return
+656.77%
AUM
$550B
AUM Growth
+$69.1B
Cap. Flow
-$11.9B
Cap. Flow %
-2.17%
Top 10 Hldgs %
32.74%
Holding
3,886
New
45
Increased
996
Reduced
1,636
Closed
163

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$1.73B
2
ETN icon
Eaton
ETN
+$1.21B
3
STX icon
Seagate
STX
+$1.1B
4
TT icon
Trane Technologies
TT
+$1.02B
5
ACN icon
Accenture
ACN
+$1.01B

Sector Composition

Rank Sector Weight
1 Technology 40.05%
2 Financials 11.12%
3 Healthcare 9.54%
4 Consumer Discretionary 9.09%
5 Communication Services 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OTEX icon
3176
Open Text
OTEX
$5.84B
$13.3K ﹤0.01%
599
FVCB icon
3177
FVCBankcorp
FVCB
$331M
$13.2K ﹤0.01%
752
TECX
3178
Tectonic Therapeutic
TECX
$721M
$13.1K ﹤0.01%
382
NKSH icon
3179
National Bankshares
NKSH
$261M
$12.7K ﹤0.01%
350
TIMB icon
3180
TIM SA
TIMB
$8.68B
$12.7K ﹤0.01%
593
OR icon
3181
OR Royalties Inc
OR
$7.28B
$12.7K ﹤0.01%
400
TCI icon
3182
Transcontinental Realty Investors
TCI
$342M
$12.6K ﹤0.01%
275
ALT icon
3183
Altimmune
ALT
$605M
$12.6K ﹤0.01%
4,154
SPMO icon
3184
Invesco S&P 500 Momentum ETF
SPMO
$21.9B
$12.6K ﹤0.01%
78
FPE icon
3185
First Trust Preferred Securities and Income ETF
FPE
$6.3B
$12.5K ﹤0.01%
700
GLSI icon
3186
Greenwich LifeSciences
GLSI
$269M
$12.2K ﹤0.01%
521
XOMA
3187
DELISTED
Xoma
XOMA
$12K ﹤0.01%
283
ARCT icon
3188
Arcturus Therapeutics
ARCT
$456M
$12K ﹤0.01%
1,787
PIO icon
3189
Invesco Global Water ETF
PIO
$277M
$12K ﹤0.01%
267
BBW icon
3190
Build-A-Bear
BBW
$491M
$12K ﹤0.01%
391
ZLAB icon
3191
Zai Lab
ZLAB
$2.92B
$11.9K ﹤0.01%
628
ESTA icon
3192
Establishment Labs
ESTA
$2.14B
$11.9K ﹤0.01%
139
-48,276
-100% -$3.47M
JAKK icon
3193
Jakks Pacific
JAKK
$301M
$11.9K ﹤0.01%
510
QCLN icon
3194
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$587M
$11.7K ﹤0.01%
191
HIFS icon
3195
Hingham Institution for Saving
HIFS
$658M
$11.7K ﹤0.01%
38
CXDO icon
3196
Crexendo
CXDO
$214M
$11.7K ﹤0.01%
1,560
NATR icon
3197
Nature's Sunshine
NATR
$251M
$11.6K ﹤0.01%
532
IPAY icon
3198
Amplify Mobile Payments ETF
IPAY
$189M
$11.6K ﹤0.01%
251
XTN icon
3199
State Street SPDR S&P Transportation ETF
XTN
$374M
$11.6K ﹤0.01%
100
DYNF icon
3200
BlackRock US Equity Factor Rotation ETF
DYNF
$40.9B
$11.6K ﹤0.01%
170
-691
-80% -$45K

Similar funds

UBS AM's Q2 2026 Portfolio in Review

As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.

  • UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
  • UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
  • UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
  • UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
  • UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
  • UBS AM opened 45 new positions and closed 163 in Q2 2026.
  • UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.